Kizoo invests in groundbreaking technologies targeting the root causes of aging to extend healthy lifespans. Their portfolio includes companies developing rejuvenation therapies for blood vessels, arterial plaque removal, calcification reversal, crosslink-breaking drugs, stem cell rejuvenation, and therapeutic mitochondria transfer. Historically, they have also backed Germany’s Internet & SaaS unicorns.
Preferred startup development maturity for initial funding deployment.
Never-done-before technologies in rejuvenation biotech and longevity, as well as seed and mentorship investments in Internet & SaaS (historically)
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...